Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -293,423 | -9,756 | -7,012 | -3,753 | 1,439 |
| Depreciation Amortization | 5 | 4 | 3 | 1 | 23 |
| Accounts payable and accrued liabilities | -1,059 | -784 | -711 | -968 | -198 |
| Other Working Capital | -632 | -147 | 299 | -618 | -321 |
| Other Operating Activity | 281,598 | 1,652 | 1,307 | 1,265 | -20,494 |
| Operating Cash Flow | $-13,511 | $-9,030 | $-6,114 | $-4,072 | $-19,551 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 74,451 | -45 | 0 | 0 | 0 |
| Financing Cash Flow | $74,451 | $-45 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 21,462 | 21,462 | 21,462 | 21,462 | 41,013 |
| End Cash Position | 82,402 | 12,387 | 15,348 | 17,390 | 21,462 |
| Net Cash Flow | $60,940 | $-9,075 | $-6,114 | $-4,072 | $-19,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,511 | -9,030 | -6,114 | -4,072 | -19,551 |
| Free Cash Flow | -13,511 | -9,030 | -6,114 | -4,072 | -19,551 |